MDGL
Madrigal Pharmaceuticals Inc
518.80$
-0.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.47 | 42.72 | |
| 0.24 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 | 0.03 | 0.29 | 2.50 | |
| -0.24 | 0.00 | 0.00 | 0.03 | -0.01 | -0.01 | -0.03 | 0.00 | 0.00 | 0.00 | 8.17 | 40.22 | |
| 24.24 | 317.04 | 3.06 | 1.99 | 1.72 | 4.70 | 11.96 | 12.41 | 14.32 | 14.57 | 11.13 | 17.32 | |
| 5.60 | 78.31 | 1.78 | 0.63 | 1.03 | 1.47 | 1.42 | 2.26 | 2.81 | 5.79 | 20.45 | 36.28 | |
| 29.59 | 18.54 | 4.85 | 2.62 | 2.75 | 6.17 | 13.38 | 14.66 | 17.13 | 20.36 | 31.58 | 53.59 | |
| -29.83 | -18.54 | -4.85 | -2.62 | -2.75 | -6.17 | -13.38 | -14.66 | -17.13 | -20.36 | -23.40 | -13.38 | |
| 0.79 | 6.20 | 0.22 | 0.05 | 0.52 | 0.72 | 0.28 | 0.06 | 0.23 | 0.68 | 0.69 | 0.99 | |
| -30.62 | -401.56 | -5.07 | -2.54 | -2.22 | -5.45 | -13.09 | -14.63 | -17.23 | -19.99 | -21.90 | -12.85 | |
| 0.00 | 0.00 | 0.00 | -0.05 | 0.53 | -0.72 | -0.31 | -0.05 | 0.23 | – | -21.90 | – | |
| -30.62 | -40.03 | -5.07 | -2.54 | -2.22 | -4.73 | -12.78 | -14.58 | -17.23 | -19.99 | -21.90 | -12.85 | |
| -29.59 | -18.90 | -4.85 | -2.61 | -2.74 | -6.16 | -13.35 | -14.64 | -16.98 | -19.28 | -21.16 | -11.79 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.